Curve DAO Token

Halal Rating :
Uncomfortable
Last Price $0.51 Last updated:
Rank 100
1D Change 7.24 %
Market Cap $658.1m
Circulating supply 1,280,993,267
Maximum supply None

Crypto Overview

Categories
  • Decentralized Exchange (DEX) Token
  • DeFi
  • DAO
  • Ethereum Ecosystem
  • Yield Farming
  • AMM
  • Governance
  • Framework Ventures Portfolio
  • Alameda Research Portfolio
  • Polygon Ecosystem
  • Fantom Ecosystem
  • Arbitrum Ecosystem
  • Optimism Ecosystem
  • DWF Labs Portfolio
  • Base Ecosystem
  • Gnosis Chain Ecosystem

Purpose and Utility

Curve DAO Token (CRV) is the governance token of Curve Finance, a decentralized exchange optimized for stablecoin trading with minimal slippage. CRV has specific utilities: governance rights over the Curve protocol, boosting liquidity provider rewards, and receiving trading fees from the platform.

Business Model Analysis

The core business model revolves around facilitating efficient stablecoin and other pegged-asset trading. The protocol generates revenue through trading fees, which are distributed to CRV stakers. While the trading aspect is halal, it's important to note that Curve's lending and borrowing features raise concerns from a Shariah perspective.

Real-World Adoption

Curve has significant adoption in the DeFi ecosystem, with billions in Total Value Locked (TVL). The protocol is actively used for its intended purposes of stablecoin trading and governance.

Development Activity

The platform shows strong development activity with regular updates and improvements. The developer community is active, and the protocol continues to evolve with new features and security improvements.

Token Distribution

CRV has a transparent token distribution model with 62% allocated to community liquidity providers, 30% to shareholders and team (with vesting), and 8% to employees. The vesting schedule extends over 2-4 years, showing commitment to long-term development.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion